104 related articles for article (PubMed ID: 9000804)
1. Molecular basis of cis-diamminedichloroplatinum(II) resistance: a review.
Chao CC
J Formos Med Assoc; 1996 Dec; 95(12):893-900. PubMed ID: 9000804
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of cisplatin resistance.
Galluzzi L; Senovilla L; Vitale I; Michels J; Martins I; Kepp O; Castedo M; Kroemer G
Oncogene; 2012 Apr; 31(15):1869-83. PubMed ID: 21892204
[TBL] [Abstract][Full Text] [Related]
3. Insights into mechanisms of cisplatin resistance and potential for its clinical reversal.
Gosland M; Lum B; Schimmelpfennig J; Baker J; Doukas M
Pharmacotherapy; 1996; 16(1):16-39. PubMed ID: 8700790
[TBL] [Abstract][Full Text] [Related]
4. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
Chu G
J Biol Chem; 1994 Jan; 269(2):787-90. PubMed ID: 8288625
[TBL] [Abstract][Full Text] [Related]
5. Resistance to cisplatin.
Akiyama S; Chen ZS; Sumizawa T; Furukawa T
Anticancer Drug Des; 1999 Apr; 14(2):143-51. PubMed ID: 10405641
[TBL] [Abstract][Full Text] [Related]
6. The role of DNA repair pathways in cisplatin resistant lung cancer.
O'Grady S; Finn SP; Cuffe S; Richard DJ; O'Byrne KJ; Barr MP
Cancer Treat Rev; 2014 Dec; 40(10):1161-70. PubMed ID: 25458603
[TBL] [Abstract][Full Text] [Related]
7. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repair.
Chao CC
Mol Pharmacol; 1994 Jun; 45(6):1137-44. PubMed ID: 8022407
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin: mode of cytotoxic action and molecular basis of resistance.
Siddik ZH
Oncogene; 2003 Oct; 22(47):7265-79. PubMed ID: 14576837
[TBL] [Abstract][Full Text] [Related]
9. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
[TBL] [Abstract][Full Text] [Related]
10. Recognition and repair of DNA-cisplatin adducts.
Woźniak K; Błasiak J
Acta Biochim Pol; 2002; 49(3):583-96. PubMed ID: 12422229
[TBL] [Abstract][Full Text] [Related]
11. Enhanced excision repair of DNA damage due to cis-diamminedichloroplatinum(II) in resistant cervix carcinoma HeLa cells.
Chao CC
Eur J Pharmacol; 1994 Aug; 268(3):347-55. PubMed ID: 7805758
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin resistance and oncogenes--a review.
Dempke W; Voigt W; Grothey A; Hill BT; Schmoll HJ
Anticancer Drugs; 2000 Apr; 11(4):225-36. PubMed ID: 10898536
[TBL] [Abstract][Full Text] [Related]
13. Understanding cisplatin resistance using cellular models.
Stordal B; Davey M
IUBMB Life; 2007 Nov; 59(11):696-9. PubMed ID: 17885832
[TBL] [Abstract][Full Text] [Related]
14. In vitro studies on the mechanisms of oxaliplatin resistance.
Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
[TBL] [Abstract][Full Text] [Related]
15. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants.
Liu B; Cvijic ME; Jetzt A; Chin KV
Cell Growth Differ; 1996 Aug; 7(8):1105-12. PubMed ID: 8853907
[TBL] [Abstract][Full Text] [Related]
17. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
O'Neill CF; Koberle B; Masters JR; Kelland LR
Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
[TBL] [Abstract][Full Text] [Related]
18. [Platinum salts: cytotoxic mechanisms of action, mechanisms of resistance of cancer cells, interactions with ionizing radiation, specificity of carboplatin].
Rixe O
Bull Cancer; 2000 Aug; 87 Spec No():7-15. PubMed ID: 11082717
[TBL] [Abstract][Full Text] [Related]
19. Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation.
Evans DL; Tilby M; Dive C
Cancer Res; 1994 Mar; 54(6):1596-603. PubMed ID: 8137265
[TBL] [Abstract][Full Text] [Related]
20. Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms.
Zhang R; Niu Y; Zhou Y
Toxicol Lett; 2010 Feb; 192(2):108-14. PubMed ID: 19853026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]